Alzheimer's disease (AD) is the most common cause of dementia in the elderly, affecting
roughly half of those over the age of 85. We briefly discussed the risk factors, epidemiology …

Alzheimer's disease (AD) is a neurodegenerative disease causing progressive cognitive
decline until eventual death. AD affects millions of individuals worldwide in the absence of …

Alzheimer disease (AD) is the most common dementing illness. The prevalence of AD
increases with age, and the disease is becoming a significant health problem as the aging …

Background. Alzheimer's disease (AD) is a progressive neurodegenerative disorder
affecting many individuals worldwide with no effective treatment to date. AD is characterized …

Neuroimaging biomarkers have potential role in the early diagnosis as well as periodic
follow-up of neurodegenerative diseases such as Alzheimer's disease (AD). Structural …

With the recent advances in treatment of Alzheimer's disease (AD) in the last decade, focus
has shifted increasingly to accurate detection of earliest phase of the illness. This includes …

With the increasing life expectancy in developed countries, the incidence of Alzheimer's
disease (AD) and thus its socioeconomic impact are growing. Increasing knowledge over …

The techniques of CT and MRI are the most commonly used instrumental aids in the
diagnosis of dementia and Alzheimer's disease. Their use is often uncritical or suboptimal as …

Alzheimer disease (AD) is a significant health problem with increasing costs to patients,
families, and society. Historically, AD has been diagnosed clinically in living patients using …

Alzheimer's disease (AD) is one of the most devastating and cosily disorders affecting the
aging population. Structural imaging (computed tomography [CT] and magnetic resonance …